The Good, the Bad, and the Ugly: Should We Completely Banish Human Albumin from Our Intensive Care Units? [RETRACTED]
- 1 October 2000
- journal article
- retracted article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 91 (4) , 887-895
- https://doi.org/10.1097/00000539-200010000-00022
Abstract
Human albumin is still widely used in critically ill patients for volume replacement therapy or for correcting hypoproteinemia. Most meta-analyses on the value of albumin administration are over 15 yr old and raise more questions than they answer. With the help of a MEDLINE analysis, we examined more recent studies in humans using albumin. Most of these studies have recommended a very cautious use of albumin in critically ill patients.This publication has 77 references indexed in Scilit:
- Practice parameters for hemodynamic support of sepsis in adult patients in sepsisCritical Care Medicine, 1999
- The Rationale for Fluid Restriction During Treatment for ARDSSeminars in Respiratory and Critical Care Medicine, 1997
- RETRACTED ARTICLE: Influence of different volume therapies on platelet function in the critically illIntensive Care Medicine, 1996
- QUANTITATIVE AND QUALITATIVE PLATELET FUNCTION AFTER TRANSFUSIONAnesthesiology, 1994
- Immune consequences of hypovolemic shock and resuscitationCurrent Opinion In Anesthesiology, 1993
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Effect of hypoalbuminemia and parenteral nutrition on free water excretion and electrolyte-free water resorptionCritical Care Medicine, 1992
- Effects of Hetastarch and Albumin on Coagulation in Patients with Septic ShockThe Journal of Clinical Pharmacology, 1988
- Analbuminaemia: a natural model of metabolic compensatory systemsJournal of Inherited Metabolic Disease, 1986
- Hypotension Associated with Prekallikrein Activator (Hageman-Factor Fragments) in Plasma Protein FractionNew England Journal of Medicine, 1978